株式会社極東書店トップ商品一覧Purine Metabolism in Man-IV: Part B: Biochemical, Immunological, and Cancer Research. Softcover reprint of the original 1st ed. 1984

商品詳細

Purine Metabolism in Man-IV: Part B: Biochemical, Immunological, and Cancer Research. Softcover reprint of the original 1st ed. 1984

Purine Metabolism in Man-IV: Part B: Biochemical, Immunological, and Cancer Research. Softcover reprint of the original 1st ed. 1984

・ISBN 978-1-4757-0392-4 paper EUR 99.99

¥26,726.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者De Bruyn, Chris H. (ed.),
シリーズ (Advances in Experimental Medicine and Biology)
出版社 (Springer-Verlag New York Inc., US)
出版年月2012
ページ数520 pp.
言語ENG
ニュース番号<A04-89850>

解説

These two volumes, entitled "Purine Metabolism in Man IV" con- tain the papers presented at the Fourth International Symposium on Human Purine and Pyrimidine Metabolism", held in Maastricht (The Netherlands), June 1982. The proceedings of the three previous meet- ings in Tel Aviv (Israel, 1973), Baden (Austria, 1976) and Madrid (Spain, 1979) were also published by Plenum Press. In the past few years interest in purine and pyrimidine metabo- lism under normal and pathological conditions has been growing rapid- ly. Apart from the more or less classical topics such as hyperuricae- mia, clinical gout and urolithiasis, an increasing number of papers relating to other fields have been presented at successive meetings. Knowledge derived from the study of purine metabolism in relation to lymphocyte function, for instance, has opened up new possibilities for immunomodulation and leukaemia chemotherapy, with eventual conse- quences for other types of cancer. At previous meetings there have been pointers implicating purine metabolism in relation to normal cardiac and skeletal muscle function. During the present meeting mych new data on both issues have been re- ported which indicate clear differences in the pathways of ATP metabo- lism. The widening of the field of interest is also illustrated by the recent work on infectious disease: exploitation of the differences in purine metabolic pathways in certain parasites compared with those in human cells has resulted in new rationales for therapy being devel- oped.